Completion of eMARx Acquisition-Issue of Equity

Summary by AI BETAClose X

MedPal AI plc has announced the issuance of 1,075,872 new ordinary shares, comprising £16,547 in cash and 904,442 shares valued at approximately £49,744 as final consideration for the eMARx acquisition, bringing the total consideration to approximately £446,633. Additionally, 171,430 shares were issued at 5.0 pence each in lieu of £8,571.50 cash to a management team member. These new shares will be admitted to AIM on 9 September 2026, increasing the company's total voting rights to 779,118,302 ordinary shares.

Disclaimer*

UK 100

Latest directors dealings